Molecular, cellular and systemic aspects of epithelial ovarian cancer and its tumor microenvironment
Open accessThe DOI matches its Crossref record; 269 of the 269 references it cites were found in a registry or an index.
Abstract
Ovarian cancer encompasses a heterogeneous group of malignancies that involve the ovaries, fallopian tubes and the peritoneal cavity. Despite major advances made within the field of cancer, the majority of patients with ovarian cancer are still being diagnosed at an advanced stage of the disease due to lack of effective screening tools. The overall survival of these patients has, therefore, not substantially improved over the past decades. Most patients undergo debulking surgery and treatment with chemotherapy, but often micrometastases remain and acquire resistance to the therapy, eventually leading to disease recurrence. Here, we summarize the current knowledge in epithelial ovarian cancer development and metastatic progression. For the most common subtypes, we focus further on the properties and functions of the immunosuppressive tumor microenvironment, including the extracellular matrix. Current and future treatment modalities are discussed and finally we provide an overview of the different experimental models used to develop novel therapies.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Items 201–269 of 269
Impact of ascites volume on clinical outcomes in ovarian cancer: A cohort study
Szender, J. B., Emmons, T. R., Belliotti, S., Dickson, D., Khan, A., Morrell, K., Khan, A. N. M. N., Singel, K. L., Mayor, P. C., Moysich, K. B., et al. (2017) · Gynecologic Oncology · doi:10.1016/j.ygyno.2017.06.008 · Cited by 78
Fishman, D. A., Kearns, A. S., Chilukuri, K., Bafetti, L. M., O’Toole, E. A., Georgacopoulos, J., Ravosa, M. J., & Stack, M. S. (1998) · Invasion and Metastasis · doi:10.1159/000024495 · Cited by 78
Selective integrin endocytosis is driven by interactions between the integrin α-chain and AP2
De Franceschi, N., Arjonen, A., Elkhatib, N., Denessiouk, K., Wrobel, A. G., Wilson, T. A., Pouwels, J., Montagnac, G., Owen, D. J., & Ivaska, J. (2016) · Nature Structural & Molecular Biology · doi:10.1038/nsmb.3161 · Cited by 77
Banet, N., & Kurman, R. J. (2014) · International Journal of Gynecological Pathology · doi:10.1097/pgp.0000000000000120 · Cited by 76
Regulation of RAD51 at the Transcriptional and Functional Levels: What Prospects for Cancer Therapy?
Orhan, E., Velázquez, C., Tabet, I., Sardet, C., & Theillet, C. G. (2021) · Cancers · doi:10.3390/cancers13122930 · Cited by 76
Rådestad, E., Klynning, C., Stikvoort, A., Mogensen, O. E., Nava, S., Magalhaes, I., & Uhlin, M. (2018) · OncoImmunology · doi:10.1080/2162402x.2018.1535730 · Cited by 73
Self-citationKaimal, R., Aljumaily, R. M., Tressel, S. L., Pradhan, R. V., Covic, L., Kuliopulos, A., Zarwan, C., Kim, Y. B., Sharifi, S., & Agarwal, A. (2013) · Cancer Research · doi:10.1158/0008-5472.can-12-1426 · Cited by 72
Kooi, S., Zhang, H., Patenia, R. S., Edwards, C. L., Platsoucas, C. D., & Freedman, R. S. (1996) · Cellular Immunology · doi:10.1006/cimm.1996.0301 · Cited by 71
Baert, T., Camp, J. V., Vanbrabant, L., Busschaert, P., Laenen, A., Han, S., Nieuwenhuysen, E. V., Vergote, I. B., & Coosemans, A. (2018) · Gynecologic Oncology · doi:10.1016/j.ygyno.2018.05.004 · Cited by 71
Morse, C. B., Toukatly, M. N., Kilgore, M., Agnew, K. J., Bernards, S. S., Norquist, B. M., Pennington, K. P., Garcia, R. L., Liao, J. B., & Swisher, E. M. (2019) · Gynecologic Oncology · doi:10.1016/j.ygyno.2019.02.011 · Cited by 69
Adaptive RSK‐EphA2‐GPRC5A signaling switch triggers chemotherapy resistance in ovarian cancer
Moyano‐Galceran, L., Pietilä, E. A., Turunen, S. P., Corvigno, S., Hjerpe, E., Bulanova, D. R., Joneborg, U., Alkasalias, T., Miki, Y., Yashiro, M., et al. (2020) · EMBO Molecular Medicine · doi:10.15252/emmm.201911177 · Cited by 68
Self-citationNovel Therapeutic Strategies for Ovarian Cancer Stem Cells
Terraneo, N., Jacob, F., Dubrovska, A., & Grünberg, J. (2020) · Frontiers in Oncology · doi:10.3389/fonc.2020.00319 · Cited by 68
Prognostic value of E-cadherin immunoexpression in patients with primary ovarian carcinomas
Faleiro-Rodrigues, C., Macedo-Pinto, I., Pereira, D., & Lopes, C. (2004) · Annals of Oncology · doi:10.1093/annonc/mdh387 · Cited by 68
Fluid-Flow Induced Wall Shear Stress and Epithelial Ovarian Cancer Peritoneal Spreading
Avraham-Chakim, L., Elad, D., Zaretsky, U., Kloog, Y., Jaffa, A., & Grisaru, D. (2013) · PLoS ONE · doi:10.1371/journal.pone.0060965 · Cited by 67
Hao, D., Li, J., Jia, S., Meng, Y., Zhang, C., Wang, L., & Di, L. (2017) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-17-0638 · Cited by 64
Regulation of invasion and peritoneal dissemination of ovarian cancer by mesothelin manipulation
Coelho, R., Ricardo, S. A. V., Amaral, A. L., Huang, Y., Nunes, M., Neves, J. P., Mendes, N. M., López, M. N., Bartosch, C., Ferreira, V., et al. (2020) · Oncogenesis · doi:10.1038/s41389-020-00246-2 · Cited by 64
Immunological configuration of ovarian carcinoma: features and impact on disease outcome
Fucikova, J. P., Coosemans, A., Oršulić, S., Cibula, D., Vergote, I. B., Galluzzi, L., & Špíšek, R. (2021) · Journal for ImmunoTherapy of Cancer · doi:10.1136/jitc-2021-002873 · Cited by 62
Pease, J. C., BREWER, M. A., & Tirnauer, J. S. (2012) · Biology Open · doi:10.1242/bio.2012653 · Cited by 62
The effects of size and shape of the ovarian cancer spheroids on the drug resistance and migration
Gunay, G., Kirit, H. A., Kamatar, A., Baghdasaryan, O., Hamsici, S., & Acar, H. (2020) · Gynecologic Oncology · doi:10.1016/j.ygyno.2020.09.002 · Cited by 62
Frankel, A., Rosen, K. V., Filmus, J., & Kerbel, R. S. (2001) · PubMed · Cited by 61
A change in microsatellite instability caused by cisplatin-based chemotherapy of ovarian cancer
Watanabe, Y., Koi, M., Hemmi, H., Hoshai, H., & Noda, K. (2001) · British Journal of Cancer · doi:10.1054/bjoc.2001.2037 · Cited by 59
Emerging Trends in Neoadjuvant Chemotherapy for Ovarian Cancer
Patel, A. P., Iyer, P., Matsuzaki, S., Matsuo, K., Sood, A. K., & Fleming, N. D. (2021) · Cancers · doi:10.3390/cancers13040626 · Cited by 59
Ray-Coquard, I. L., Cibula, D., Mirza, M. R., Reuß, A., Ricci, C., Colombo, N., Koch, H., Goffin, F., González-Martín, A., Ottevanger, P. B., et al. (2019) · International Journal of Cancer · doi:10.1002/ijc.32606 · Cited by 59
Malacrida, B., Nichols, S. J., Maniati, E., Jones, R. R., Delanie-Smith, R., Roozitalab, R., Tyler, E. J., Thomas, M., Boot, G. F., Mackerodt, J., et al. (2021) · iScience · doi:10.1016/j.isci.2021.102676 · Cited by 57
Nath, S., Pigula, M. L., Khan, A. P., Hanna, W., Ruhi, M. K., Dehkordy, F. M., Pushpavanam, K., Rege, K., Moore, K., Tsujita, Y., et al. (2020) · Journal of Clinical Medicine · doi:10.3390/jcm9040924 · Cited by 57
Quantitative imaging of RAD51 expression as a marker of platinum resistance in ovarian cancer
Hoppe, M. M., Jaynes, P. W., Wardyn, J. D., Srinivas, U. S., Tan, T. Z., Lie, S., Lim, D. G., Pang, B., Lim, S., Yeong, J. P.-S., et al. (2021) · EMBO Molecular Medicine · doi:10.15252/emmm.202013366 · Cited by 57
Mastelic-Gavillet, B., Sarivalasis, A., Lozano, L. E., Wyss, T., Inogés, S., de Vries, I. J., Dartiguenave, F., Jichlinski, P., Derré, L., Coukos, G., et al. (2020) · European Journal of Cancer · doi:10.1016/j.ejca.2020.04.036 · Cited by 56
Henriksen, J. R., Donskov, F. N., Waldstrøm, M., Jakobsen, A. K. M., Hjortkjær, M., Petersen, C. B., & Steffensen, K. D. (2020) · Acta Oncologica · doi:10.1080/0284186x.2019.1711173 · Cited by 56
Carduner, L., Leroy‐Dudal, J., Picot, C. R., Gallet, O., Carreiras, F., & Kellouche, S. (2014) · Clinical & Experimental Metastasis · doi:10.1007/s10585-014-9658-1 · Cited by 54
Ma, L., Sun, Y., Li, D., Li, H., Jin, X., & Ren, D. (2020) · Aging · doi:10.18632/aging.102954 · Cited by 54
Human bone marrow niche chemoprotection mediated by cytochrome p450 enzymes
Alonso, S., Su, M., Jones, J. W., Ganguly, S., Kane, M. A., Jones, R. J., & Ghiaur, G. (2015) · Oncotarget · doi:10.18632/oncotarget.3614 · Cited by 53
Constitutive activation of integrin αvβ3 contributes to anoikis resistance of ovarian cancer cells
Dolinschek, R., Hingerl, J., Benge, A., Zafiu, C., Schüren, E., Ehmoser, E.-K., Loessner, D., & Reuning, U. (2020) · Molecular Oncology · doi:10.1002/1878-0261.12845 · Cited by 53
Hyperthermic intraperitoneal chemotherapy does not improve survival in advanced ovarian cancer
Vergote, I. B., Harter, P., & Chiva, L. M. (2019) · Cancer · doi:10.1002/cncr.32496 · Cited by 53
Blanc‐Durand, F., Genestie, C., Yaniz‐Galende, E., Gouy, S., Morice, P., Pautier, P., Maulard, A., Mesnage, S. J. L., Formal, A. L., Brizais, C., et al. (2020) · Gynecologic Oncology · doi:10.1016/j.ygyno.2020.09.045 · Cited by 52
Human-Derived Model Systems in Gynecological Cancer Research
Lõhmussaar, K., Boretto, M., & Clevers, H. C. (2020) · Trends in cancer · doi:10.1016/j.trecan.2020.07.007 · Cited by 51
The latest animal models of ovarian cancer for novel drug discovery
Magnotti, E. L., & Marasco, W. A. (2018) · Expert Opinion on Drug Discovery · doi:10.1080/17460441.2018.1426567 · Cited by 51
Krugmann, J., Schwarz, C. L., Melcher, B., Sterlacci, W., Ožalinskaitė, A., Lermann, J., Agaimy, A., & Vieth, M. W. (2018) · Archives of Gynecology and Obstetrics · doi:10.1007/s00404-018-4952-9 · Cited by 50
The role of MMP-14 in ovarian cancer: a systematic review
Vos, M. C., van der Wurff, A. A. M., Kuppevelt, T. H. V., & Massuger, L. F. A. G. (2021) · Journal of Ovarian Research · doi:10.1186/s13048-021-00852-7 · Cited by 49
Asem, M., Young, A., Oyama, C., Zerda, A. C. D. L., Liu, Y., Ravosa, M. J., Gupta, V. G., Jewell, A., Khabele, D., & Stack, M. S. (2020) · Scientific Reports · doi:10.1038/s41598-020-68639-2 · Cited by 49
The prognostic values of matrix metalloproteinases in ovarian cancer
Zeng, L., Qian, J., Zhu, F., Wu, F., Zhao, H., & Zhu, H. (2019) · Journal of International Medical Research · doi:10.1177/0300060519825983 · Cited by 49
Chan, D. W., Lam, W.-Y., Chen, F., Yung, M. M. H., Chan, Y.-S., Chan, W.-S., He, F., Liu, S. S., Chan, K. K. L., Li, B. C., et al. (2021) · Clinical Epigenetics · doi:10.1186/s13148-021-01130-5 · Cited by 45
Mouse models of epithelial ovarian cancer for preclinical studies
Karakashev, S. V., & Zhang, R. (2021) · 动物学研究 · doi:10.24272/j.issn.2095-8137.2020.382 · Cited by 42
Clinical relevance of circulating tumor cells in ovarian, fallopian tube and peritoneal cancer
Banys-Paluchowski, M. J., Fehm, T. N., Neubauer, H. J., Paluchowski, P., Krawczyk, N., Meier-Stiegen, F., Wallach, C., Kaczerowsky, A., & Gebauer, G. (2020) · Archives of Gynecology and Obstetrics · doi:10.1007/s00404-020-05477-7 · Cited by 41
Vankerckhoven, A., Wouters, R., Mathivet, T., Ceusters, J., Baert, T., Hoylandt, A. V., Gerhardt, H., Vergote, I. B., & Coosemans, A. (2020) · Cells · doi:10.3390/cells9020305 · Cited by 39
Hinchcliff, E., Hong, D. S., Le, H., Chisholm, G. B., Iyer, R. B., Naing, A., Hwu, P., & Jazaeri, A. A. (2018) · Gynecologic Oncology · doi:10.1016/j.ygyno.2018.10.008 · Cited by 37
Fu, Z., Xu, S., Xu, Y., Ma, J., Li, J., & Xu, P. (2015) · International Journal of Gynecological Cancer · doi:10.1097/igc.0000000000000386 · Cited by 36
Invariant natural killer T infiltration in neuroblastoma with favorable outcome
Hishiki, T., Mise, N., Harada, K., Ihara, F., Takami, M., Saito, T., Terui, K., Nakata, M., Komatsu, S., Yoshida, H., et al. (2017) · Pediatric Surgery International · doi:10.1007/s00383-017-4189-x · Cited by 36
Wefers, C., Boer, T. D., Yigit, R., Zusterzeel, P. L. M., van Altena, A. M., Massuger, L. F. A. G., & de Vries, I. J. M. (2019) · Frontiers in Immunology · doi:10.3389/fimmu.2018.03156 · Cited by 33
Coelho, R., Marcos-Silva, L., Mendes, N. M., Pereira, D., Brito, C., Jacob, F., Steentoft, C., Mandel, U., Clausen, H., David, L., et al. (2018) · International Journal of Molecular Sciences · doi:10.3390/ijms19072045 · Cited by 31
Genetic risk factors for ovarian cancer and their role for endometriosis risk
Burghaus, S., Fasching, P. A., Häberle, L., Rübner, M., Büchner, K., Blum, S., Engel, A., Ekici, A. B., Hartmann, A., Hein, A., et al. (2017) · Gynecologic Oncology · doi:10.1016/j.ygyno.2017.02.022 · Cited by 30
Kenny, H. A., Lal‐Nag, M., Shen, M., Kara, B., Nahotko, D. A., Wroblewski, K., Fazal, S., Chen, S., Chiang, C.-Y., Chen, Y., et al. (2019) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-19-0052 · Cited by 30
The multicellular signalling network of ovarian cancer metastases
Sommerfeld, L., Finkernagel, F., Jansen, J. M., Wagner, U. A. G., Nist, A., Stiewe, T., Müller‐Brüsselbach, S., Sokòl, A. M., Graumann, J., Reinartz, S., et al. (2021) · Clinical and Translational Medicine · doi:10.1002/ctm2.633 · Cited by 29
Host Mesothelin Expression Increases Ovarian Cancer Metastasis in the Peritoneal Microenvironment
Hilliard, T. S., Kowalski, B., Iwamoto, K., Agadi, E., Liu, Y., Yang, J., Asem, M., Klymenko, Y., Johnson, J. J., Shi, Z., et al. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms222212443 · Cited by 29
Santin, A. D., Ravindranath, M. H., Bellone, S., Muthugounder, S., Palmieri, M., O’Brien, T. J., Roman, J. J., Cannon, M. J., & Pecorelli, S. L. (2004) · BJOG An International Journal of Obstetrics & Gynaecology · doi:10.1111/j.1471-0528.2004.00142.x · Cited by 29
Horst, E. N., Bregenzer, M. E., Mehta, P., Snyder, C. S., Repetto, T., Yang‐Hartwich, Y., & Mehta, G. (2021) · Acta Biomaterialia · doi:10.1016/j.actbio.2021.04.041 · Cited by 27
Matsuzaki, S., Bourdel, N., Darcha, C., Déchelotte, P. J., Bazin, J.-É., Pouly, J. L., Mage, G., & Canis, M. J. (2008) · Surgical Endoscopy · doi:10.1007/s00464-008-0041-7 · Cited by 25
Salman, L., Sabah, G., Jakobson‐Setton, A., Raban, O., Yeoshoua, E., & Eitan, R. (2019) · International Journal of Gynecology & Obstetrics · doi:10.1002/ijgo.12986 · Cited by 25
Zheng, H., Tie, Y., Wang, X., Yang, Y., Wei, X., & Zhao, X. (2019) · Medicine · doi:10.1097/md.0000000000014577 · Cited by 24
Gallon, J., Loomis, E. W., Curry, E. W., Martin, N. G., Brody, L., Garner, I., Brown, R., & Flanagan, J. M. (2021) · Clinical Epigenetics · doi:10.1186/s13148-021-01105-6 · Cited by 23
Defining the molecular evolution of extrauterine high grade serous carcinoma
Beirne, J., McArt, D. G., Roddy, A. C., McDermott, C., Ferris, J. S., Buckley, N. E., Coulter, P., McCabe, N., Eddie, S. L., Dunne, P. D., et al. (2019) · Gynecologic Oncology · doi:10.1016/j.ygyno.2019.08.029 · Cited by 22
Relationship between ascites volume and clinical outcomes in epithelial ovarian cancer
Quan, Q., Zhou, S., Liu, Y., Yin, W., Liao, Q., Ren, S., Zhang, F., Meng, Y., & Mu, X. (2021) · Journal of obstetrics and gynaecology research · doi:10.1111/jog.14682 · Cited by 22
Seraya-Bareket, C., Weisz, A., Shinderman‐Maman, E., Teper-Roth, S., Stamler, D., Arbib, N., Kadan, Y., Fishman, A., Kidron, D., Edelstein, E., et al. (2020) · Oncogenesis · doi:10.1038/s41389-020-00254-2 · Cited by 20
Magalhaes, I., Fernebro, J., Own, S. A., Glaessgen, D., Corvigno, S., Remberger, M., Mattsson, J., & Dahlstrand, H. M. (2020) · Advances in Therapy · doi:10.1007/s12325-020-01520-w · Cited by 18
Self-citationTakeshita, Y., Motohara, T., Kadomatsu, T., Doi, T., Obayashi, K., Oike, Y., Katabuchi, H., & Endo, M. (2021) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2021.05.008 · Cited by 16
Wang, J., Li, J., Chen, R., Yue, H., Li, W., Wu, B., Bai, Y., Zhu, G., & Lü, X. (2021) · Clinical Epigenetics · doi:10.1186/s13148-021-01178-3 · Cited by 15
Nasioudis, D., Byrne, M. E., Ko, E. M., Haggerty, A. F., Cory, L. A., Giuntoli, R. L., Kim, S. H., & Latif, N. (2021) · International Journal of Gynecological Cancer · doi:10.1136/ijgc-2021-002978 · Cited by 14
SJI 2020 special issue: A catalogue of Ovarian Cancer targets for CAR therapy
Benard, E., Casey, N. P., Inderberg, E. M., & Wälchli, S. (2020) · Scandinavian Journal of Immunology · doi:10.1111/sji.12917 · Cited by 13
Chiang, C. L.-L., Rovelli, R., Sarivalasis, A., & Kandalaft, L. E. (2021) · Cancers · doi:10.3390/cancers13184553 · Cited by 13
Kast, V., & Loessner, D. (2021) · Advances in experimental medicine and biology · doi:10.1007/978-3-030-73359-9_9 · Cited by 11
Metadata
- Authors
- Schoutrop, E., Moyano-Galceran, L., Lheureux, S., Mattsson, J., Lehti, K., Dahlstrand, H., & Magalhaes, I.
- Venue
- Seminars in Cancer Biology
- Publisher
- Elsevier BV
- Published
- 2022-11
- Volume
- 86
- Issue
- Pt 3
- Pages
- 207-223
- ISSN
- 1044-579X (ISSN-L)
- OpenAlex
- W4223430921
- Cited by
- 176
- References
- 269
- FWCI
- 24.08
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.